BRPI0915473A2 - composto, composição farmacêutica, e, uso de um composto - Google Patents

composto, composição farmacêutica, e, uso de um composto

Info

Publication number: BRPI0915473A2
Authority: BR; Brazil
Prior art keywords: compound; pharmaceutical composition; pharmaceutical; composition
Prior art date: 2008-07-08

Application number

BRPI0915473A

Other languages

English (en)

Inventor

Akihiro Tamura

Keiko Suzuki

Mitsuhiro Yamaguchi

Takahiro Yamaguchi

Tomohiro Nishizawa

Original Assignee

Daiichi Sankyo Co Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2008-07-08

Filing date

2009-07-07

Publication date

2015-11-10

2009-07-07 Application filed by Daiichi Sankyo Co Ltd filed Critical Daiichi Sankyo Co Ltd

2015-11-10 Publication of BRPI0915473A2 publication Critical patent/BRPI0915473A2/pt

Links

150000001875 compounds Chemical class 0.000 title 2
239000008194 pharmaceutical composition Substances 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
- A61K31/4155—1,2-Diazoles non condensed and containing further heterocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A61K31/422—Oxazoles not condensed and containing further heterocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4245—Oxadiazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
- C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
- C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Medicinal Chemistry (AREA)
Epidemiology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Diabetes (AREA)
Obesity (AREA)
Hematology (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Urology & Nephrology (AREA)
Endocrinology (AREA)
Hospice & Palliative Care (AREA)
Vascular Medicine (AREA)
Child & Adolescent Psychology (AREA)
Gastroenterology & Hepatology (AREA)
Emergency Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Pyrrole Compounds (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Thiazole And Isothizaole Compounds (AREA)
Pyridine Compounds (AREA)

BRPI0915473A 2008-07-08 2009-07-07 composto, composição farmacêutica, e, uso de um composto BRPI0915473A2 (pt)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
JP2008178377		2008-07-08
PCT/JP2009/062331 WO2010004972A1 (ja)	2008-07-08	2009-07-07	含窒素芳香族ヘテロシクリル化合物

Publications (1)

Publication Number	Publication Date
BRPI0915473A2 true BRPI0915473A2 (pt)	2015-11-10

Family

ID=41507085

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BRPI0915473A BRPI0915473A2 (pt)	2008-07-08	2009-07-07	composto, composição farmacêutica, e, uso de um composto

Country Status (24)

Country	Link
US (2)	US8648103B2 (pt)
EP (1)	EP2308838B1 (pt)
JP (1)	JP5461398B2 (pt)
KR (1)	KR20110025742A (pt)
CN (1)	CN102149680B (pt)
AU (1)	AU2009269178B2 (pt)
BR (1)	BRPI0915473A2 (pt)
CA (1)	CA2730078A1 (pt)
CO (1)	CO6341610A2 (pt)
CY (1)	CY1117503T1 (pt)
DK (1)	DK2308838T3 (pt)
ES (1)	ES2566529T3 (pt)
HR (1)	HRP20160236T1 (pt)
HU (1)	HUE028595T2 (pt)
IL (1)	IL210498A0 (pt)
MX (1)	MX2011000044A (pt)
NZ (1)	NZ590790A (pt)
PL (1)	PL2308838T3 (pt)
RU (1)	RU2481330C2 (pt)
SI (1)	SI2308838T1 (pt)
SM (1)	SMT201600119B (pt)
TW (1)	TWI435875B (pt)
WO (1)	WO2010004972A1 (pt)
ZA (1)	ZA201100183B (pt)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ES2566529T3 (es) *	2008-07-08	2016-04-13	Daiichi Sankyo Company, Limited	Compuesto heterociclilo aromático que contiene nitrógeno
WO2012147916A1 (ja)	2011-04-28	2012-11-01	日本たばこ産業株式会社	アミド化合物およびその医薬用途
US20160137639A1 (en) *	2012-10-26	2016-05-19	Japan Tobacco Inc.	Triazole-isoxazole compound and medical use thereof
WO2014073989A1 (en) *	2012-11-12	2014-05-15	Callaghan Innovation Research Limited	Salt and polymorphic forms of (3r,4s)-l-((4-amino-5h-pyrrolo[3,2-d]pyrimidin-7-yl)methyl)-4(methylthiomethyl)pyrodin-3-ol(mtdia)
TWI636047B (zh)	2013-08-14	2018-09-21	英商卡爾維斯塔製藥有限公司	雜環衍生物
GB201421083D0 (en)	2014-11-27	2015-01-14	Kalvista Pharmaceuticals Ltd	Enzyme inhibitors
ME03794B (me)	2016-05-31	2021-04-20	Kalvista Pharmaceuticals Ltd	Derivati pirazola kao inhibitori kalikreina plazme
GB201609607D0 (en)	2016-06-01	2016-07-13	Kalvista Pharmaceuticals Ltd	Polymorphs of N-(3-Fluoro-4-methoxypyridin-2-yl)methyl)-3-(methoxymethyl)-1-({4-((2-oxopy ridin-1-yl)methyl)phenyl}methyl)pyrazole-4-carboxamide and salts
GB201719881D0 (en)	2017-11-29	2018-01-10	Kalvista Pharmaceuticals Ltd	Solid forms of plasma kallikrein inhibitor and salts thereof
PL3716952T3 (pl)	2017-11-29	2022-05-02	Kalvista Pharmaceuticals Limited	Postacie dawkowania zawierające inhibitor kalikreiny osoczowej
WO2021028645A1 (en)	2019-08-09	2021-02-18	Kalvista Pharmaceuticals Limited	Plasma kallikrein inhibitors
KR20260041885A (ko)	2023-07-25	2026-03-27	몬테 로사 테라퓨틱스 아게	표적화된 단백질 분해를 위한 치환된 피페리딘디온

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
NZ548212A (en)	2003-12-29	2010-07-30	Sepracor Inc	Pyrrole and pyrazole DAAO inhibitors
JP2008518957A (ja)	2004-11-04	2008-06-05	メルクエンドカムパニーインコーポレーテッド	ナイアシン受容体作動薬、そのような化合物を含んでいる組成物及び治療方法
EP1811996A1 (en)	2004-11-05	2007-08-01	Arena Pharmaceuticals, Inc.	Compositions for treating flushing and lipid-associated disorders comprising niacin receptor partial agonists
JP2008520715A (ja)	2004-11-23	2008-06-19	メルクエンドカムパニーインコーポレーテッド	ナイアシン受容体アゴニスト、そのような化合物を含む組成物、および治療方法
GB0503053D0 (en)	2005-02-14	2005-03-23	Smithkline Beecham Corp	Chemical compounds
GB0505735D0 (en)	2005-03-21	2005-04-27	Glaxo Group Ltd	Compounds
CA2611552A1 (en)	2005-06-28	2007-01-04	Merck & Co., Inc.	Niacin receptor agonists, compositions containing such compounds and methods of treatment
WO2007015744A1 (en) *	2005-07-21	2007-02-08	Incyte Corporation	Disubstituted thienyl compounds and their use as pharmaceuticals
DE602006012358D1 (de) *	2005-11-18	2010-04-01	Dabur Pharma Ltd	Zielgerichtete fusionsproteine für die krebstherapie
EP1792901A1 (en) *	2005-11-22	2007-06-06	Bayer CropScience S.A.	N-(1-alkyl-2-phenylethyl)-carboxamide derivatives and use thereof as fungicides
CA2633042A1 (en)	2005-12-20	2007-07-05	Merck & Co., Inc.	Niacin receptor agonists, compositions containing such compounds and methods of treatment
CA2641307A1 (en)	2006-02-07	2007-08-16	Merck & Co., Inc.	Niacin receptor agonists, compositions containing such compounds and methods of treatment
EP2010512A4 (en)	2006-04-11	2010-02-24	Merck & Co Inc	Niacin receptor agonists, compositions containing such compounds and method of treatment
ES2566529T3 (es) *	2008-07-08	2016-04-13	Daiichi Sankyo Company, Limited	Compuesto heterociclilo aromático que contiene nitrógeno

2009
- 2009-07-07 ES ES09794416.9T patent/ES2566529T3/es active Active
- 2009-07-07 CN CN200980134944.5A patent/CN102149680B/zh not_active Expired - Fee Related
- 2009-07-07 PL PL09794416T patent/PL2308838T3/pl unknown
- 2009-07-07 BR BRPI0915473A patent/BRPI0915473A2/pt not_active IP Right Cessation
- 2009-07-07 JP JP2010519777A patent/JP5461398B2/ja not_active Expired - Fee Related
- 2009-07-07 CA CA2730078A patent/CA2730078A1/en not_active Abandoned
- 2009-07-07 KR KR1020107025572A patent/KR20110025742A/ko not_active Withdrawn
- 2009-07-07 RU RU2011104223/04A patent/RU2481330C2/ru not_active IP Right Cessation
- 2009-07-07 EP EP09794416.9A patent/EP2308838B1/en active Active
- 2009-07-07 SI SI200931400A patent/SI2308838T1/sl unknown
- 2009-07-07 AU AU2009269178A patent/AU2009269178B2/en not_active Ceased
- 2009-07-07 HU HUE09794416A patent/HUE028595T2/en unknown
- 2009-07-07 DK DK09794416.9T patent/DK2308838T3/da active
- 2009-07-07 WO PCT/JP2009/062331 patent/WO2010004972A1/ja not_active Ceased
- 2009-07-07 US US13/001,806 patent/US8648103B2/en not_active Expired - Fee Related
- 2009-07-07 TW TW098122847A patent/TWI435875B/zh not_active IP Right Cessation
- 2009-07-07 HR HRP20160236TT patent/HRP20160236T1/hr unknown
- 2009-07-07 NZ NZ590790A patent/NZ590790A/xx not_active IP Right Cessation
- 2009-07-07 MX MX2011000044A patent/MX2011000044A/es not_active Application Discontinuation
2011
- 2011-01-06 IL IL210498A patent/IL210498A0/en unknown
- 2011-01-06 ZA ZA2011/00183A patent/ZA201100183B/en unknown
- 2011-01-13 CO CO11003214A patent/CO6341610A2/es active IP Right Grant
2014
- 2014-02-10 US US14/177,000 patent/US9150563B2/en not_active Expired - Fee Related
2016
- 2016-04-22 SM SM201600119T patent/SMT201600119B/it unknown
- 2016-05-13 CY CY20161100405T patent/CY1117503T1/el unknown

Also Published As

Publication number	Publication date
EP2308838B1 (en)	2016-02-17
US8648103B2 (en)	2014-02-11
HRP20160236T1 (hr)	2016-05-06
PL2308838T3 (pl)	2016-08-31
IL210498A0 (en)	2011-03-31
CN102149680A (zh)	2011-08-10
EP2308838A1 (en)	2011-04-13
TWI435875B (zh)	2014-05-01
US20120108639A1 (en)	2012-05-03
RU2481330C2 (ru)	2013-05-10
US9150563B2 (en)	2015-10-06
TW201004950A (en)	2010-02-01
DK2308838T3 (da)	2016-05-17
WO2010004972A1 (ja)	2010-01-14
KR20110025742A (ko)	2011-03-11
RU2011104223A (ru)	2012-08-20
CY1117503T1 (el)	2017-04-26
JP5461398B2 (ja)	2014-04-02
CN102149680B (zh)	2014-12-10
ES2566529T3 (es)	2016-04-13
NZ590790A (en)	2012-09-28
MX2011000044A (es)	2011-02-22
EP2308838A4 (en)	2012-05-09
HUE028595T2 (en)	2016-12-28
ZA201100183B (en)	2012-06-27
US20140187592A1 (en)	2014-07-03
SI2308838T1 (sl)	2016-09-30
CA2730078A1 (en)	2010-01-14
AU2009269178B2 (en)	2012-09-06
HK1155443A1 (en)	2012-05-18
JPWO2010004972A1 (ja)	2012-01-05
SMT201600119B (it)	2016-07-01
AU2009269178A1 (en)	2010-01-14
CO6341610A2 (es)	2011-11-21

Legal Events

Date	Code	Title	Description
2016-09-13	B08F	Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]	Free format text: REFERENTE AS 6A E 7A ANUIDADES.
2017-01-10	B08K	Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]	Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2384 DE 13-09-2016 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.

Publication	Publication Date	Title
BRPI0919942A2 (pt)	2014-12-23	Composto, composição farmacêutica, e, uso de um composto
BRPI0907562A2 (pt)	2017-05-23	composto, composição farmacêutica, e, uso de um composto
BRPI0921375A2 (pt)	2015-12-29	composto, composição farmacêutica, e, uso de um composto
BRPI0810696A2 (pt)	2014-10-21	Composto, composição farmacêutica, e, uso de um composto
BRPI0917579A2 (pt)	2016-10-11	composto, composição farmacêutica, métodos, e, uso de um composto
BRPI1016219A2 (pt)	2016-04-26	composto, composição farmacêutica, e, uso de um composto
BRPI1008793A2 (pt)	2016-03-08	composto, uso de um composto, e, composição farmacêutica
BRPI0921879A2 (pt)	2018-10-16	composto, composição farmacêutica , e, uso de um composto
BRPI1007018A2 (pt)	2016-03-29	composto, composição farmacêutica, e , uso de um composto.
BRPI0810161A2 (pt)	2014-12-30	Composto, preparação farmacêutica, composição farmacêutica, e, uso de um composto
BRPI1008906A2 (pt)	2016-03-15	composto, composição farmacêutica, e, uso de um composto.
BRPI0815709A2 (pt)	2017-06-13	composro, composição farmacêutica, e, uso de um composto.
BRPI0906937A2 (pt)	2016-04-19	composto, composição farmacêutica, e, uso de um composto
BR112013008259A2 (pt)	2017-12-12	composto, composição farmacêutica, e, uso de um composto
BRPI0917001A2 (pt)	2016-02-16	composto, composição farmacêutica, e, uso de um composto ou uma composição farmacêutica
BRPI0812942A2 (pt)	2014-12-16	Composto, composição farmacêutica e uso de um composto
BR112013015397A2 (pt)	2016-09-20	composto, composição farmacêutica, e, uso de um composto
BRPI0915134A2 (pt)	2016-02-16	composto, e, uso de um composto
BRPI0918360A2 (pt)	2017-10-10	composto, composição farmacêutica e usos de um composto
BRPI0810019A2 (pt)	2014-10-14	Composto, composição farmacêutica, e, uso de um composto
BRPI0716171A2 (pt)	2013-09-17	composto, composiÇço farmacÊutica e uso de um composto.
BRPI0821115A2 (pt)	2015-06-16	Composto derivado de aminotriazol, medicamento, composição farmacêutica e uso do composto
BRPI1009757A2 (pt)	2016-03-15	composto, composição farmacêutica, e , uso de um composto.
BRPI0919165A2 (pt)	2015-12-08	composição farmacêutica,e, uso de um composto
BRPI0918517A2 (pt)	2015-12-01	composto, composição farmacêutica, e, uso de um composto